DNDN Developments
The most expected course of action was taken by the FDA. Still a bit ambiguous as it leaves the FDA with the decision to disregard the interim results. I say this because the FDA already disregarded an obvious positive review from the Advisory Commitee, so they can also most certainly disregard positive interim data.
If DNDN learned anything from the strong arm tactics from the corruption within the FDA, they will partner with a high powered big boy now. They can still go at it alone, but that will require a secondary, and if they do plan on going alone, the secondary should come very soon. But observing the corruption of the FDA they will need a partner to get Provenge through and to market by 2008.
The stock is currently trading at its true value (between 8-10). When a partner is announced DNDN could go to 15. But if a secondary is announced, and DNDN tries to go at it alone, the stock could very well see 4-6 again.
(The reason I use the word CORRUPTION… the minority voices of the FDA with OBVIOUS conflicts of interest were able to sway the FDA decision against the FDA’s own findings within the Briefing Documents and overwhelming majority opinion of an Advisory Commitee. I define this as CORRUPT!)
